Tag: alpha spending

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks In the realm of clinical trials, particularly adaptive platform trials, interim analyses serve as critical checkpoints that can influence the overall study trajectory. This tutorial aims to provide an in-depth understanding of the operational and regulatory risks…

Read More “Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks” »

Setting Up Independent Data Monitoring Committees (DMC/IDMC) The establishment and operation of Independent Data Monitoring Committees (DMC) or Independent Data Monitoring Committees (IDMC) is crucial in clinical trials for ensuring participant safety and the integrity of data. This guide provides a step-by-step approach to setting up a DMC, focusing on compliance with regulatory requirements in…

Read More “Setting Up Independent Data Monitoring Committees (DMC/IDMC)” »

When to Plan Interim Analyses for Efficacy, Futility and Safety When to Plan Interim Analyses for Efficacy, Futility and Safety Understanding Interim Analyses in Clinical Trials Interim analyses are critical evaluations conducted at predetermined time points during a clinical trial, primarily aimed at ensuring the study is on track in terms of efficacy, safety, and…

Read More “When to Plan Interim Analyses for Efficacy, Futility and Safety” »

Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond In the realm of clinical trials, the management of alpha spending during interim analyses is crucial for maintaining the integrity of statistical inferences. This guide aims to provide a comprehensive overview of alpha spending functions such as O’Brien-Fleming and Pocock, along…

Read More “Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond” »

Interim Analyses in Clinical Trials: Design, Timing and Governance Interim analyses are critical checkpoints in the lifecycle of clinical trials, providing essential data that can influence the trajectory of a study. These evaluations allow stakeholders to make informed decisions regarding the continuation, modification, or termination of a trial based on interim results. This tutorial aims…

Read More “Interim Analyses in Clinical Trials: Design, Timing and Governance” »